press release/media: For the Treatment of Second-Line Platinum Sensitive Advanced Ovarian Cancer, One-Third of Surveyed Oncologists Indicate That Paclitaxel/Carboplatin Has the Best Overall Clinical Profile When Compared to Other Currently Available Therapies
Ovarian Cancer and Us
OVARIAN CANCER and US
Ovarian Cancer and Us
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.